Risk Perception and Preference for Prevention of Alzheimer's Disease

被引:21
|
作者
Chung, Sukyung [1 ]
Mehta, Kala [1 ]
Shumway, Martha [1 ]
Alvidrez, Jennifer [1 ]
Perez-Stable, Eliseo J. [1 ]
机构
[1] Univ Calif San Francisco, Phillip R Lee Inst Hlth Policy Studies, Palo Alto, CA 94301 USA
关键词
Alzheimer's disease; prevention preference; risk perception; willingness to pay; AFRICAN-AMERICANS; CARDIOVASCULAR HEALTH; COGNITIVE DECLINE; PERCEIVED RISK; DEMENTIA RISK; CANCER-RISK; WHITE; OLDER; POPULATION; PREVALENCE;
D O I
10.1111/j.1524-4733.2008.00482.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
To understand how older adults perceive their risk of Alzheimer's Disease (AD) and how this may shape their medical care decisions, we examined whether presence of established risk factors of AD is associated with individuals' perceived risk of AD, and with preference for preventing AD. Participants: Data came from the US Health and Retirement Study participants who were asked questions on AD risk perception (N = 778). Measurements: Perceived risk of AD was measured by respondents' estimate of their percent chance (0-100) developing AD in the next 10 years. Preference for AD prevention was measured with questions eliciting willingness to pay for a drug to prevent AD. Analysis: Multivariate linear regressions were used to estimate correlates of perceived risk and preference for prevention. Better cognitive functioning and physical activity are associated with decreased perceived risk. Neither age nor cardiovascular disease is associated with perceived risk. African Americans have lower perceived risk than non-Latino whites; the difference is wider among people age 65 and above. Only 4% to 7% of the variation in perceived risk was explained by the model. Preference for prevention is stronger with increased perceived risk, but not with the presence of risk factors. Persons with better cognitive functioning, physical functioning, or wealth status have a stronger preference for prevention. Some known risk factors appear to inform, but only modestly, individuals' perceived risk of AD. Furthermore, decisions about AD prevention may not be determined by objective needs alone, suggesting a potential discrepancy between need and demand for AD preventive care.
引用
收藏
页码:450 / 458
页数:9
相关论文
共 50 条
  • [21] Metformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias
    Tahmi, M.
    Luchsinger, Jose A.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2023, 10 (04): : 706 - 717
  • [22] Metformin in the Prevention of Alzheimer’s Disease and Alzheimer’s Disease Related Dementias
    M. Tahmi
    José A. Luchsinger
    The Journal of Prevention of Alzheimer's Disease, 2023, 10 : 706 - 717
  • [23] Predictive genetic testing for Alzheimer's disease: Impact upon risk perception
    Marteau, TM
    Roberts, S
    LaRusse, S
    Green, RC
    RISK ANALYSIS, 2005, 25 (02) : 397 - 404
  • [24] Factors for Prevention of Alzheimer's Disease
    Ivanova, Stefka
    Kirkova-Bogdanova, Angelina
    Becheva, Maria Vakrilova
    Peikova, Lily
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2023, 52 (07) : 1536 - 1537
  • [25] Possible prevention of Alzheimer's disease
    Janoutova, J.
    Kovalova, M.
    Ambroz, P.
    Machaczka, O.
    Zatloukaloa, A.
    Nemcek, K.
    Mrazkova, E.
    Kosta, O.
    Skoloudik, D.
    Janout, V
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (01) : 28 - 32
  • [26] Choline as a prevention for Alzheimer's disease
    Velazquez, Ramon
    Winslow, Wendy
    Mifflin, Marc A.
    AGING-US, 2020, 12 (03): : 2026 - 2027
  • [27] Prevention strategies for Alzheimer's disease
    Gauthier S.
    Wu L.
    Rosa-Neto P.
    Jia J.
    Translational Neurodegeneration, 1 (1)
  • [28] Antihypertensives for prevention of Alzheimer's disease
    Birkenhager, WH
    Staessen, JA
    LANCET NEUROLOGY, 2006, 5 (06): : 466 - 468
  • [29] Nutrients in the Prevention of Alzheimer's Disease
    Cremonini, Anna Laura
    Caffa, Irene
    Cea, Michele
    Nencioni, Alessio
    Odetti, Patrizio
    Monacelli, Fiammetta
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
  • [30] Alzheimer's disease: Pathogenesis and prevention
    Braak, Heiko
    Del Tredici, Kelly
    ALZHEIMERS & DEMENTIA, 2012, 8 (03) : 227 - 233